Back to results
US 4,062,942 AGranted
Induction of ovulation with partially desialylated human chorionic gonadotropin
AssigneeSerono Laboratories, Inc.
InventorPietro Donini
Life of this patent
Estimating the term…
Abstract
Partially desialylated human Chorionic Gonadotropin is used after menotropin administration to induce ovulation.
Claims5
In the method of inducing ovulation by the sequential administration of menotropins and human chorionic gonadotropin, the improvement which comprises employing partially desialylated human chorionic gonadotropin as said human chorionic gonadotropin, wherein said partially desialylated human chorionic gonadotropin has a degree of desialylation of 15 to 35%.
Dependencies are inferred from the claim text.